| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 07/07/2011 | US20110165224 Vaccines for inclusion body hepatitis |
| 07/07/2011 | US20110165189 Rabies virus-based recombinant immunocontraceptive compositions and methods of use |
| 07/07/2011 | US20110165120 Inhibitors of serine proteases |
| 07/07/2011 | US20110165117 Immunogenic peptides and methods of use |
| 07/07/2011 | CA2785992A1 Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages |
| 07/06/2011 | EP2341080A1 Humanized immunoglobulins and their production and use |
| 07/06/2011 | EP2341068A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 07/06/2011 | EP2340304A2 A method of producing a pharmacologically stable form of lyophilised, active preparations of purified bacteriophages |
| 07/06/2011 | EP1885847B1 Scalable fermentation process |
| 07/06/2011 | CN1934243B Immortalized avian cell lines for virus production |
| 07/06/2011 | CN102115733A Construction method and application of hepatic tumor gene treatment system capable of administrating intravenously |
| 07/06/2011 | CN102115729A Method for culturing baby hamster kidney (BHK) 21 cell in serum-free way, and vaccine preparation method |
| 07/06/2011 | CN102114243A Method for preparing polyvalent vaccine of primary hamster kidney cells of flu |
| 07/06/2011 | CN101955915B Method for producing influenza virus vaccine |
| 07/05/2011 | US7972843 DNA-transfection system for the generation of infectious influenza virus |
| 07/05/2011 | US7972605 Modified vaccinia ankara virus vaccine |
| 07/05/2011 | US7972593 Delivery of therapeutic agents to the bone |
| 07/05/2011 | CA2616221C Cell line for producing coronaviruses |
| 07/05/2011 | CA2220133C Recombinant vesiculoviruses and their uses |
| 06/30/2011 | WO2011054995A3 PROPHYLACTIC FLU VACCINES FROM VIRAL CAPSIDS OF BIRNAVIRUS CONTAINING THE M2e ANTIGEN OF THE FLU VIRUS |
| 06/30/2011 | WO2011025179A3 Method of inducing the differentiation of human embryonic stem cells into mesenchymal stem cells |
| 06/30/2011 | US20110159571 Adenovirus targeting |
| 06/30/2011 | US20110159036 MVA expressing modified HIV envelope, GAG, and POL genes |
| 06/30/2011 | US20110159034 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 06/30/2011 | US20110159033 West nile virus vaccine |
| 06/30/2011 | US20110159032 Modified vaccinia virus ankara for the vaccination of neonates |
| 06/30/2011 | US20110159031 Vaccine to Influenza A Virus |
| 06/30/2011 | US20110158945 Myxoma virus mutants for cancer treatment |
| 06/30/2011 | US20110158908 Cyclosporin a-binding protein |
| 06/30/2011 | CA2783330A1 Herpes simplex virus vaccines |
| 06/29/2011 | EP2339035A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/29/2011 | EP2339011A1 West Nile virus and Dengue 4 virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus |
| 06/29/2011 | EP2339006A2 DNA constructs for expression of heterologous polypeptides in plants |
| 06/29/2011 | EP2339005A2 DNA constructs for expression of heterologous polypeptides in plants |
| 06/29/2011 | EP2338984A1 Synthetic viruses and uses thereof |
| 06/29/2011 | EP2338900A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 06/29/2011 | EP2338508A1 A rDEN3/4delta 30(ME), rDEN2/4delta30(ME) or rDEN1/4delta30(ME) recombinant chimeric dengue virus containing a 30 nucleotide deletion (delta30) in a section of the 3' untranslated region of dengue type 4 genome, wherein said 30 nucleotide deletion corresponds to the TL2 stem-loop structure. |
| 06/29/2011 | CN102112601A Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
| 06/29/2011 | CN102108336A Recombinant adenovirus vaccine containing EB (Epstein-Barr) virus membrane protein gp350/220, gp85, gp78 or gp25 gene |
| 06/29/2011 | CN102107004A Porcine reproductive and respiratory syndrome virus-like particle vaccine and preparation method thereof |
| 06/29/2011 | CN102107003A Porcine reproductive and respiratory syndrome Virosome vaccine and preparation method thereof |
| 06/28/2011 | US7968340 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 06/28/2011 | US7968333 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 06/28/2011 | US7968332 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 06/28/2011 | US7968101 Recombinant influenza vectors with tandem transcription units |
| 06/28/2011 | US7968086 Genetically stable enterovirus expression vector with replaced stem loop VI |
| 06/28/2011 | CA2400182C Full-length infectious cdna clones of tick borne flavivirus |
| 06/23/2011 | WO2011074929A1 A recombinant a/astanarg/5:3/2009 m-13-09/d flu virus strain produced by a reverse genetics method from a highly pathogenic donor strain a/chicken/astana/6/05 (h5n1) and a highly reproductive donor strain a/puerto rico/8/34 (h1n1) from the orthomyxoviridae family of the genus influenza virus type a which is deposited in the microorganism collection of the science committee at the ministry of education and science of the republic of kazakhstan state enterprise subsidiary of the scientific research institute for biological safety problems at the republican state enterprise of the national centre for biotechnology of the republic of kazakhstan and can be used in biotechnology for the production of diagnostic and vaccine preparations against a/h5n1 flu |
| 06/23/2011 | WO2011074928A1 A recombinant a/astanarg/6:2/2009 m-12-09/d flu virus strain produced by a reverse genetics method from a highly pathogenic donor strain a/chicken/astana/6/05 (h5n1) and a highly reproductive donor strain a/puerto rico/8/34 (h1n1) from the orthomyxoviridae family of the genus influenza virus type a which is deposited in the microorganism collection of the science committee at the ministry of education and science of the republic of kazakhstan state enterprise subsidiary of the scientific research institute for biological safety problems at the republican state enterprise of the national centre for biotechnology of the republic of kazakhstan and can be used in biotechnology for the production of diagnostic and vaccine preparations against a/h5n1 flu |
| 06/23/2011 | US20110154538 Infectious Plant Viral Vector and An Artificial Bipartite Plant Viral Vector An Infectious Plant Viral Vector and An Artificial Bipartite Plant Viral Vector |
| 06/23/2011 | US20110152352 Smad proteins control drosha-mediated mirna maturation |
| 06/23/2011 | US20110151543 Cell separation method using hydrophobic solid supports |
| 06/23/2011 | US20110151542 Bionanomaterials and Their Synthesis |
| 06/23/2011 | US20110151512 Oligopeptide-free cell culture media |
| 06/23/2011 | US20110151434 Adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 06/23/2011 | US20110150929 SARS vaccine compositions and methods of making and using them |
| 06/23/2011 | US20110150928 Unique avian reoviridae |
| 06/23/2011 | US20110150925 Cell-based systems for producing influenza vaccines |
| 06/23/2011 | US20110150913 Torque teno virus (ttv) isolates and compositions |
| 06/23/2011 | US20110150912 Avian influenza virus live attenuated vaccine and uses thereof |
| 06/23/2011 | US20110150907 Methods and materials for gastrointestinal delivery of pathogen/toxin binding agents |
| 06/23/2011 | US20110150840 Detection and Treatment of Glyco-Enzyme-Related Disease |
| 06/23/2011 | US20110150827 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
| 06/23/2011 | US20110150771 Chimeric west nile/dengue viruses |
| 06/22/2011 | EP2336370A2 Recombinant Newcastle disease virus RNA expression systems and vaccines |
| 06/22/2011 | EP2336368A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/22/2011 | EP2336304A1 Flow through purification processes for large biomolecules |
| 06/22/2011 | EP2336176A1 Antibodies directed against hepatitis c virus e1e2 complex, and their epitopes |
| 06/22/2011 | EP2334328A1 Methods for purification of viruses |
| 06/22/2011 | EP1831381B1 Methods to obtain recombinant proteins with increased sialylation from cells that express adenovirus e1a protein, and proteins obtained thereby |
| 06/22/2011 | CN1990859B Method of nucleus receptor ligand binding domain protein fusion expression on bacteriophage surface |
| 06/22/2011 | CN1981040B Recombinant virus vector for gene introduction in lymphocyte |
| 06/22/2011 | CN1384885B Preparation method of recombinant adenoviruses and adenovirus banks |
| 06/22/2011 | CN1244896B Non-M, non-O, HIV-1 strains, fragments and applications |
| 06/22/2011 | CN102100910A Method for producing viral vaccines |
| 06/21/2011 | US7964398 Modified vaccinia ankara virus variant and cultivation method |
| 06/21/2011 | US7964397 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 06/21/2011 | US7964396 Modified vaccinia ankara virus variant and cultivation method |
| 06/21/2011 | US7964395 Modified vaccinia ankara virus variant and cultivation method |
| 06/21/2011 | US7964374 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 06/21/2011 | US7964186 modified adenovirus containing mutation in or lacks the virus associated RNA gene, modified HSV, vaccinia virus and parapoxvirus; Ras-activated pathway; neoplasm; immunosuppressant |
| 06/21/2011 | CA2455499C Method for purification of viral vectors having proteins which bind sialic acid |
| 06/21/2011 | CA2316739C Preparation of cells for production of biologicals |
| 06/16/2011 | WO2011070440A2 Oncolytic rhabdovirus |
| 06/16/2011 | WO2011048503A3 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
| 06/16/2011 | US20110143424 Recombinant influenza viruses for vaccines and gene therapy |
| 06/16/2011 | US20110143423 Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small-molecule regulator |
| 06/16/2011 | US20110143422 Recovery of recombinant human parainfluenza virus type 2 (hypiv2) from cdna and use of recombinant hpiv2 in immunogenic compositions and as vectors to elicit immune responses against piv and other human pathogens |
| 06/16/2011 | US20110142879 Infectious clones |
| 06/16/2011 | US20110142878 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use |
| 06/16/2011 | US20110142863 Flow through purification processes for large biomolecules |
| 06/16/2011 | US20110142811 Measles virus for the elimination of unwanted cell populations |
| 06/16/2011 | US20110142798 Hepatitis c virus inhibitors |
| 06/16/2011 | CA2836117A1 Oncolytic rhabdovirus |
| 06/15/2011 | EP2333065A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 06/15/2011 | EP2332574A1 HCV NS3/4A Sequences |
| 06/15/2011 | EP2332573A1 Chimeric alphavirus replicon particles |
| 06/15/2011 | EP2331682A1 Infectious bronchitis vaccines derived from ib-qx-like strains |
| 06/15/2011 | EP2331557A1 Alphavirus packaging cell lines |
| 06/15/2011 | EP2331117A1 Vaccines containing canine parvovirus genetic variants |